Diseases targeted |
Chagas |
Scientific genus “Trypanosoma cruzi” |
Leishmaniasis |
Scientific genus “Leishmania” |
Malaria |
Scientific name “Plasmodium” |
Tuberculosis |
Scientific genus “Mycobacterium” was not used because shared with other different diseases. Only the species name was used |
HIV |
Scientific genus “Lentivirus” |
Infectious diseases |
Patents targeting a group of diseases not limited to a single NTDs, or patents targeting other relevant NTDs such as leprosy and dengue |
Invention use |
Diagnostic |
An invention concerned with the medical diagnosis of an illness or disease or the diagnosis of a species, genus, or phenomenon |
Therapeutic |
An invention concerned with the treatment, therapy and/or prevention of either an illness or disease |
Diagnostic and therapeutic |
Inventions that fall in both categories |
Invention type |
Device |
Any device with the intended use within the field of medicine for any medical purpose related to a given disease or illness |
Method |
Any method or process or series of steps for performing a function or accomplishing a medical result |
Compound |
A chemical substance composed of molecules or molecular entities formed of atoms from more than one element held together by a chemical bond |
Vaccine compound |
A series of compounds for use in the creation of a product that stimulates a person’s immune system to produce immunity to a specific disease |
Drug compound |
Any number of compounds for the creation of a product for medicinal use |
Topical medication |
Any medication applied to a particular place on or in the body |
Applicants’ origin |
Brazil |
The applicant is (the member of) a Brazilian organization |
Other |
The applicant is from another country |